{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:03:44Z","timestamp":1792757024931,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.cell.2023.11.015","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T11:09:27Z","timestamp":1702379367000},"page":"5705-5718.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":188,"title":["Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis"],"prefix":"10.1016","volume":"186","author":[{"given":"Hannes","family":"Vietzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"K\u00fchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe L.","family":"Furlano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Bsteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Rommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Puchhammer-St\u00f6ckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2023.11.015_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.11.015_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.cell.2023.11.015_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226436","article-title":"Primary Epstein-Barr virus infection with and without infectious mononucleosis","volume":"14","author":"Rostgaard","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cell.2023.11.015_bib4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood.2022017650","article-title":"HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD","volume":"141","author":"Vietzen","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.cell.2023.11.015_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2023.11.015_bib6","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cell.2023.11.015_bib7","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3390\/cells11172757","article-title":"Altered immune response to the Epstein-Barr virus as a prerequisite for multiple sclerosis","volume":"11","author":"L\u00e4derach","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cell.2023.11.015_bib8","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1186\/s12889-022-13971-7","article-title":"A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development","volume":"22","author":"Fowler","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cell.2023.11.015_bib9","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1111\/ene.14961","article-title":"Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis\u2014a presymptomatic case\u2013control study","volume":"28","author":"Grut","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cell.2023.11.015_bib10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/ene.13622","article-title":"Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the \u2018hygiene hypothesis\u2019?","volume":"25","author":"Alari-Pahissa","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cell.2023.11.015_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","article-title":"Elevated Epstein\u2013Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis","volume":"67","author":"L\u00fcnemann","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2023.11.015_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420956495","article-title":"Relapsing and progressive MS: the sex-specific perspective","volume":"13","author":"Rommer","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.cell.2023.11.015_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S1474-4422(06)70581-6","article-title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study","volume":"5","author":"Orton","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2023.11.015_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","article-title":"Multiple sclerosis: doubling down on MHC","volume":"37","author":"Martin","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.cell.2023.11.015_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-2094-10-35","article-title":"Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status","volume":"10","author":"Vogel","year":"2013","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.cell.2023.11.015_bib16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ijc.33859","article-title":"NKG2A is a late immune checkpoint on CD8 T\u00a0cells and marks repeated stimulation and cell division","volume":"150","author":"Borst","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cell.2023.11.015_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41590-018-0082-6","article-title":"Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells","volume":"19","author":"Hammer","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib18","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2014-05-576124","article-title":"Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions","volume":"124","author":"Goodier","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cell.2023.11.015_bib19","doi-asserted-by":"crossref","first-page":"39231","DOI":"10.1038\/srep39231","article-title":"A functional polymorphism in the NKG2D gene modulates NK-cell cytotoxicity and is associated with susceptibility to human papilloma virus-related cancers","volume":"6","author":"Espinoza","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2023.11.015_bib20","doi-asserted-by":"crossref","first-page":"960852","DOI":"10.3389\/fimmu.2022.960852","article-title":"Implications of NKG2A in immunity and immune-mediated diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib21","first-page":"938561","article-title":"IL-27 driven upregulation of surface HLA-E expression on monocytes inhibits IFN-\u03b3 release by autologous NK cells","volume":"2014","author":"Morandi","year":"2014","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.cell.2023.11.015_bib22","doi-asserted-by":"crossref","first-page":"19973","DOI":"10.1038\/s41598-020-76344-3","article-title":"Epstein\u2013Barr virus peptides derived from latent cycle proteins alter NKG2A\u00a0+ NK cell effector function","volume":"10","author":"Mbiribindi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2023.11.015_bib23","doi-asserted-by":"crossref","first-page":"869447","DOI":"10.3389\/fimmu.2022.869447","article-title":"Natural killer cells in multiple sclerosis: entering the stage","volume":"13","author":"Beli\u00ebn","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib24","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.3389\/fimmu.2019.02865","article-title":"Phenotypic and functional analysis of human NK cell subpopulations according to the expression of Fc\u03b5RI\u03b3 and NKG2C","volume":"10","author":"Kim","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41590-022-01327-7","article-title":"Clonal expansion and epigenetic inheritance of long-lasting NK cell memory","volume":"23","author":"R\u00fcckert","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fimmu.2018.00441","article-title":"NKG2D: a master regulator of immune cell responsiveness","volume":"9","author":"Wensveen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib27","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lopez-Verg\u00e8s","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2023.11.015_bib28","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1212\/WNL.0b013e31821e552a","article-title":"Common viruses associated with lower pediatric multiple sclerosis risk","volume":"76","author":"Waubant","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2023.11.015_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molmed.2014.11.002","article-title":"Cytomegalovirus: a culprit or protector in multiple sclerosis?","volume":"21","author":"Vanheusden","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cell.2023.11.015_bib30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1179\/016164106X98134","article-title":"Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients","volume":"28","author":"Zivadinov","year":"2006","journal-title":"Neurol. Res."},{"key":"10.1016\/j.cell.2023.11.015_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/1352458515601215","article-title":"Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis","volume":"22","author":"Mart\u00ednez-Rodr\u00edguez","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.cell.2023.11.015_bib32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.16564","article-title":"Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis","volume":"12","author":"Li","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cell.2023.11.015_bib33","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0002-9440(10)62340-1","article-title":"Analysis of interleukin-27 (EBI3\/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells","volume":"166","author":"Larousserie","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2023.11.015_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-017-0919-1","article-title":"Increased interleukin-27 cytokine expression in\u00a0the\u00a0central nervous system of multiple sclerosis patients","volume":"14","author":"Lalive","year":"2017","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.cell.2023.11.015_bib35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/glia.22948","article-title":"Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: modulation of local immune responses","volume":"64","author":"S\u00e9n\u00e9cal","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.cell.2023.11.015_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1262","article-title":"The IL-27\/IL-27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients","volume":"10","author":"Cl\u00e9net","year":"2021","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.cell.2023.11.015_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","article-title":"The immunobiology of interleukin-27","volume":"33","author":"Yoshida","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib38","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T\u00a0cells","volume":"8","author":"Fitzgerald","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17\u2013producing T\u00a0cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib40","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.4049\/jimmunol.1200808","article-title":"IFN-\u03b3 limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27","volume":"189","author":"Murugaiyan","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cell.2023.11.015_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaut.2016.04.003","article-title":"Dysregulation of regulatory CD56bright NK cells\/T cells interactions in multiple sclerosis","volume":"72","author":"Laroni","year":"2016","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.cell.2023.11.015_bib42","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/aws159","article-title":"Natural killer cells and their receptors in multiple sclerosis","volume":"136","author":"Kaur","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cell.2023.11.015_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046120","article-title":"Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients","volume":"7","author":"J\u00f8rgensen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cell.2023.11.015_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/imm.12012","article-title":"Increased HLA-E expression in white matter lesions in multiple sclerosis","volume":"137","author":"Durrenberger","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.cell.2023.11.015_bib45","doi-asserted-by":"crossref","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cell.2023.11.015_bib46","doi-asserted-by":"crossref","first-page":"eadg3032","DOI":"10.1126\/sciadv.adg3032","article-title":"Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis","volume":"9","author":"Thomas","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cell.2023.11.015_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2023.11.015_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/infdis\/jiaa097","article-title":"Human cytomegalovirus (HCMV)-specific antibody response and development of antibody-dependent cellular cytotoxicity against HCMV after lung transplantation","volume":"222","author":"Vietzen","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2023.11.015_bib49","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.3390\/ijms22158206","article-title":"Analysis and fine specificity of the HCMV-specific cell-free and cell-associated antibody-dependent cellular phagocytosis (ADCP) responses in lung transplant recipients","volume":"22","author":"Eberhard","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cell.2023.11.015_bib50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1399-0039.1992.tb01909.x","article-title":"Rapid HLA-DRB1 genotyping by nested PCR amplification","volume":"39","author":"Bein","year":"1992","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cell.2023.11.015_bib51","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41436-020-01077-7","article-title":"Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19","volume":"23","author":"Vietzen","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.cell.2023.11.015_bib52","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1399-0039.2009.01375.x","article-title":"A high-throughput Taqman approach for the discrimination of HLA-E alleles","volume":"74","author":"Paquay","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cell.2023.11.015_bib53","doi-asserted-by":"crossref","first-page":"e02996-20","DOI":"10.1128\/mBio.02996-20","article-title":"Extent of cytomegalovirus replication in the human host depends on variations of the HLA-E\/UL40 Axis","volume":"12","author":"Vietzen","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.cell.2023.11.015_bib54","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/605610","article-title":"Identification of Epstein-Barr virus (EBV)\u2013infected lymphocyte subtypes by flow cytometric in\u00a0situ hybridization in EBV-associated lymphoproliferative diseases","volume":"200","author":"Kimura","year":"2009","journal-title":"J.\u00a0Infect. Dis."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867423012321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867423012321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T21:03:46Z","timestamp":1771448626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867423012321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":54,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0092867423012321"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2023.11.015","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2023.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}